In 2025, the landscape of antiviral therapy in the United States is witnessing a remarkable evolution. Among the many drugs under investigation, Ivermectin future antiviral potential USA has emerged as a promising candidate with potential applications far beyond its initial use against COVID-19. Thanks to an expanding body of U.S. clinical data on antiviral effects, researchers...